人工智能在心房的诊断和管理中的作用
Otilia Țica1, Asgher Champsi2, Jinming Duan3,4
1Cardiology Clinic, Emergency County Clinical Hospital of Bihor, 410165 Oradea, Romania.
Diagnostics (Basel, Switzerland)
|October 29, 2025
概括
人工智能 (AI) 显著改善了心房的诊断和管理. 人工智能工具增强了心电图分析,风险预测和个性化治疗,改变了心脏病治疗.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 心房动 (AF) 是最常见的心律失常.
- 人工智能 (AI) 正在成为心血管医学中的关键技术.
- 人工智能为改善AF诊断和管理提供了潜力.
研究的目的:
- 对AF诊断,风险预测和治疗指导的AI方法进行批判性评估.
- 综合人工智能的当前进展,用于AF管理.
- 评估AI在心脏病学中的临床相关性.
主要方法:
- 系统评估机器学习,深度学习 (CNN,RNN) 和NLP的AF.
- 在心电图解读和可穿戴设备监控中对人工智能应用的审查.
- 分析AI在治疗个性化和程序结果预测中的作用.
主要成果:
- 人工智能工具在心电图分析和AF预测方面表现出卓越的准确性和效率.
- 深度学习算法擅长识别AF的微妙心电图特征.
- 人工智能增强了对抗凝血,节律/速率控制和切除结果的临床决策.
结论:
- 人工智能代表了AF管理的范式转变,改善了诊断精度和患者的结果.
- 对于临床采用,必须解决数据隐私和可解释性等挑战.
- 人工智能集成有望提供个性化的护理和更好地管理心房动.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
424
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
424
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Dysrhythmias V: Evaluating Dysrhythmias
323
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
323
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
453
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
453
Aortic Regurgitation III: Medical Management
388
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
388
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312


